Conflicts of Interest Between Physicians and the Pharmaceutical Industry and Special Interest Groups

Thompson, 1993, Understanding financial conflicts of interest, N Engl J Med, 329, 573, 10.1056/NEJM199308193290812 IMS Health Financial, business and trade releases. Available at: http://www.IMS_Japan.cojp/industry_trends_press_releases_2007. Accessed September 4, 2007. Angell, 2005 Wazana, 2000, Physicians and the pharmaceutical industry. Is a gift ever just a gift?, JAMA, 283, 373, 10.1001/jama.283.3.373 Saul S. Doctors and drug makers: a move to end cozy ties. New York: New York Times 2007. p. C1. Elliott C. The drug pushers. The Atlantic Monthly. April 2006; 82–93. Public Citizen Congress Watch. 2002 Drug industry profits: hefty pharmaceutical company margins dwarf other industries. Available at: http://www.citizen.org/congress/reform/drug_industry/coproratearticles.cfm?ID=9923. Peterson, 2001, Suit says company promoted drug in exam rooms, New York Times, 1 Orlowski, 1992, The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch, Chest, 02, 270, 10.1378/chest.102.1.270 Berenson A. Drug files show maker promoted unapproved use. New York Times. December 18, 2006; A1. Brodkey, 2005, The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem, Acad Psychiatry, 29, 222, 10.1176/appi.ap.29.2.222 Wilkes, 1992, Pharmaceutical advertisements in leading medical journals: experts' assessments, Ann Intern Med, 116, 912, 10.7326/0003-4819-116-11-912 Galt, 2001, Group practice strategies to manage pharmaceutical cost in an HMO network, Am J Manag Care, 7, 1081 Bekelman, 2003, Scope and impact of financial conflicts of interest in biomedical research, JAMA, 289, 454, 10.1001/jama.289.4.454 Jacobs P. How profits, research mix at Stanford. Available at: http://www.matr.net/article_19768html1-18k. Bodenheimer, 2000, Uneasy alliance: clinical investigators and the pharmaceutical industry, N Engl J Med, 342, 1539, 10.1056/NEJM200005183422024 Anders T. Enhancing transparency of research: antidepressant medications for children and adolescents. Statement from Thomas Anders, M.D. President of the American Academy of Child and Adolescent Psychiatry. Washington, DC, February 6, 2007. Available at: http://www.aacap.org, media, press releases. Accessed September 5, 2007. Meier B. Contracts keep drug research out of reach. New York Times. November 29, 2004. 2004; 29 Angell, 2000, Is academic medicine for sale?, N Engl J Med, 342, 1516, 10.1056/NEJM200005183422009 Standbridge, 2006, Of doctor conventions and drug companies, Fam Med, 38, 518 Lurie, 2005, Violations of exhibiting and FDA rules at an American Psychiatric Association Annual Meeting, J Public Health Policy, 26, 389, 10.1057/palgrave.jphp.3200049 Kassirer JP. Doctors and drug companies. Boston Globe. July 6, 2005; 15. Relman, 2003, Defending professional independence. ACGME's proposed new guidelines for support of CME, JAMA, 14, 03 APA Annual Report 2006 Arlington, VA: American Pspychiatric Association. Hensley, 2005, Speaker programs come under the microscope again. To sell their drugs, companies increasingly rely on doctors, Wall Street Journal Kassirer, 2006, When physician-industry interactions go awry, J Pediatr, 149, S43, 10.1016/j.jpeds.2006.04.051 Topol, 2005, Physicians and the investment industry, JAMA, 293, 2654, 10.1001/jama.293.21.2654 Harris G, Robert J. Doctor's ties to drug makers are put on close view. New York Times. March 21, 2007; A1. Harris, 2005, Ten voters on panel backing pain pills had industry ties, New York Times, 24, A1 Harris G. FDA rule limits role of advisers tied to industry. New York Times. March 22, 2007; A1. American Academy of Child and Adolescent Psychiatry. Guidelines for commercial contributions to the AACAP. Available at: http://www.aacap.org. American Medical Association. Ethical opinions and guidelines. 2005. Updated clarification on Opinion E-8.061: Gifts to physicians from industry. Cooney E. Project seeks to limit ties between doctors, drug companies. White Coat Notes: news from the Boston medical community [Boston Globe]. Available at: http://boston.com/yourlife/health/blog/2007/02/prescription-pr.html. Accessed September 5, 2007. Brennan, 2006, Health industry practices that create conflicts of interest: a proposal for academic medical centers, JAMA, 295, 429, 10.1001/jama.295.4.429 Accreditation Council for Continuing Medical Education. Standards for commercial support: standards to ensure independence of CME activities. Available at: http://www.accme.org/index.cfm. Accesssed September 5, 2007. American Student Medical Association. Principles regarding pharmaceuticals and medical devices 2005. Available at: http://www.amsa.org/ppp/pharm.cfm. Accessed September 4, 2007. Pharmaceutical Research and Manufacturers of America, “Code on Interactions with Health Professionals.” Available at: http://www.phrma.org/code-on=-interractions-withhealthcare-professionals/. Accessed September 4, 2007. Dresser, 2006, Pharmaceutical company gifts: from voluntary standards to legal demands, Hastings Cent Rep, 8, 10.1353/hcr.2006.0039 Geppert, 2007, Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training, Acad Psychiatry, 31, 32, 10.1176/appi.ap.31.1.32